A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis

Journal of Gastroenterology

Volumn 45, Issue 12, 2010, Pages 1219-1227

  Ohara, Shuichi ^d   Haruma, Ken ^a   Kinoshita, Yoshikazu ^b   Kusano, Motoyasu ^c  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY HOSPITAL   (Japan)

^d NONE

Author keywords

Endoscopy; GERD; Heartburn; LA classification

Indexed keywords

FAMOTIDINE; LAFUTIDINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPY; FEMALE; HEALING; HEARTBURN; HUMAN; JAPANESE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; URIC ACID BLOOD LEVEL;

ACETAMIDES; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FAMOTIDINE; FEMALE; HEARTBURN; HISTAMINE H2 ANTAGONISTS; HUMANS; JAPAN; MALE; MIDDLE AGED; PIPERIDINES; PYRIDINES; TREATMENT OUTCOME;

EID: 78651343293     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0283-8     Document Type: Article

References (28)

1. S Ohara T Kouzu T Kawano M Kusano 2005 Nationwide epidemiological survey regarding hertburn and reflux esophagitis in Japanese (in Japanese with English abstract) Nippon shokakibyo Gakkai Zasshi (JSSG) 102 1010 1024
2. M Khan J Santana C Donnellan C Preston P Moayyedi 2007 Medical treatments in the short term management of reflux oesophagitis Cochrane database Syst Rev 18 CD003244
3. P Moayyedi NJ Talley 2006 Gastro-oesophageal reflux disease Lancet 367 2086 2100 10.1016/S0140-6736(06)68932-0 16798392
4. K Haruma T Kamada H Kawaguchi S Okamoto M Yoshihara K Sumii, et al. 2000 Effect of age and Helicobacter pylori infection on gastric acid secretion J Gastroenterol Hepatol 15 277 283 1:STN:280:DC%2BD3c3isFSqug%3D%3D 10.1046/j.1440-1746.2000.02131.x 10764028 (Pubitemid 30190741)
5. M Feldman B Cryer KE Mcarthur BA Huet E Lee 1996 Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study Gastroenterology 110 1043 1052 1:STN:280:DyaK287otlWnsg%3D%3D 10.1053/gast.1996.v110.pm8612992 8612992 (Pubitemid 26113743)
6. K Fujimoto R Iwakiri K Okamoto K Oda A Tanaka S Tsunada, et al. 2003 Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women J Gastroenterol 38 3 6 12698863
7. Y Fujiwara T Arakawa 2009 Epidemiology and clinical characteristics of GERD in the Japanese population J Gastroenterol 44 518 534 10.1007/s00535-009- 0047-5 19365600
8. T Koike S Ohara H Sekine M Kawamura Y Abe Y Inomata, et al. 2007 Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine Hepatogastroenterology 54 1280 1284 1:CAS:528:DC%2BD2sXpsFGrtrw%3D 17629089
9. T Shimatani M Inoue T Kuroiwa J Xu M Nakamura S Tazuma, et al. 2006 Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine Dig Dis Sci 51 114 120 1:CAS:528:DC%2BD28XksVyjsw%3D%3D 10.1007/s10620-006-3094-2 16416222 (Pubitemid 43106347)
10. S Ohara K Haruma Y Kinoshita M Kusano 2010 Efficacy evaluation of Lafutidine for mild reflux esophagitis in Japanese patients (in Japanese with English abstract) Nippon Shokakibyo Gakkai Zasshi (JSSG) 107 588 597
11. K Kimura T Takemoto 1969 An endoscopic recognition of the atrophic border and its significance in chronic gastritis Endoscopy 3 87 97 10.1055/s-0028-1098086
12. C Sakamoto K Sugano S Ota N Sakaki S Takahashi Y Yoshida, et al. 2006 Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflamatory drugs in Japan Eur J Clin Pharmacol 62 765 772 1:CAS:528:DC%2BD28XotlChtrc%3D 10.1007/s00228-006-0171-6 16821007 (Pubitemid 44289508)
13. R Tutuian 2010 Clinical lead outpatient services and gastrointestinal function laboratory. Adverse effects of drugs on the esophagus Best Pract Res Clin Gastroenterol 24 91 97 1:CAS:528:DC%2BC3cXjt1Wks7Y%3D 10.1016/j.bpg.2010. 02.005 20227023
14. P Ruszniewski C Soufflet P Barthelemy 2008 Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study Aliment Pharmacol Ther 28 1134 1139 1:STN:280: DC%2BD1cnptlShuw%3D%3D 10.1111/j.1365-2036.2008.03821.x 18671778
15. DN Juurlink T Gomes DT Ko PE Szmitko PC Austin JV Tu DA Henry, et al. 2009 A population-based study of the drug interaction between proton pump inhibitors and clopidogrel CMAJ 180 713 718 19176635
16. K Adachi H Fujishiro T Katsube M Yuki M Ono A Kawamura, et al. 2001 Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis J Gastroenterol Hepatol 16 1191 1196 1:STN:280: DC%2BD387mvFKlug%3D%3D 10.1046/j.1440-1746.2001.02617.x 11903734 (Pubitemid 34088263)
17. 2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease J Gastroenterol 43 448 456 1:CAS:528:DC%2BD1cXotFeju7g%3D 10.1007/s00535-008-2186- 5 18600389 (Pubitemid 351997882)
18. K Adachi Y Komazawa T Mihara T Azumi T Fujisawa T Katsube, et al. 2005 Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine J Gastroenterol Hepatol 20 1012 1015 1:CAS:528:DC%2BD2MXmvF2ktbY%3D 10.1111/j.1440-1746.2005.03917.x 15955208
19. 2 receptor antagonist, than by the proton pump inhibitor lansoprazole World J Gastroenterol 14 2406 2410 1:CAS:528:DC%2BD1cXosVagtL8%3D 10.3748/wjg.14.2406 18416470 (Pubitemid 351877614)
20. M Inamori J Togawa T Iwasaki Y Ozawa T Kikuchi K Muramatsu, et al. 2005 Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? J Gastroenterol 40 453 458 1:CAS:528:DC%2BD2MXlslGmsLc%3D 10.1007/s00535-005-1569-0 15942709 (Pubitemid 40823279)
21. T Suzuki T Yamaguchi T Odaka M Kobayashi A Seza T Kouzu 2008 Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects Aliment Pharmacol Ther 27 66 71 1:CAS:528:DC%2BD1cXhtVCntbg%3D 10.1111/j.1365-2036.2007.03545.x 17922801 (Pubitemid 350212626)
22. TJ Simon MM Berenson RG Berlin S Snapinn A Cagliola 1994 Randomized, placebo-controlled comparison of famotidine 20 mg b.d. or 40 mg b.d. in patients with erosive oesophagitis Aliment Pharmacol Ther 8 71 79 1:STN:280: DyaK2c3kt1yqsw%3D%3D 10.1111/j.1365-2036.1994.tb00162.x 8186349
23. MT Silver RH Murdock BB Morrill SO Sue 1996 Ranitidine 300 mg twice daily and 150 mg four-times daily are effective in healing erosive oesophagitis Aliment Pharmacol Ther 10 373 380 1:CAS:528:DyaK28XjvFygu74%3D 10.1111/j.0953-0673.1996.00373.x 8791966 (Pubitemid 26173886)
24. ML Cloud N Enas TJ Humphries FS Bassion 1998 Rabeprazole in the treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer and gastroesopageal reflux disease (GERD). The Rabeprazole Study Group Digest Dis Sci 43 993 1000 1:CAS:528:DyaK1cXjsVWiur8%3D 10.1023/A:1018822532736 9590413 (Pubitemid 28211458)
25. JE Richter W Bochenek 2000 Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Panatoprazole US GERD Study Group Am J Gastroenterol 95 3071 3080 1:CAS:528:DC%2BD3cXos1ygs7o%3D 10.1111/j.1572-0241.2000.03254.x 11095320
26. SJ Sontag BI Hirschowitz S Holt MG Robinson J Behar MM Berenson, et al. 1992 Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the US multicenter study Gastroenterology 102 109 118 1:STN:280: DyaK38%2FptVKisQ%3D%3D 1727744
27. M Kusano K Ino T Yamada O Kawamura M Toki T Ohwada, et al. 1999 Interobserver and intraobserver variation in endoscopic assessment of GERD using the "Los Angeles" classification Gastrointest Endosc 49 700 704 1:STN:280:DyaK1M3ns1GjtQ%3D%3D 10.1016/S0016-5107(99)70285-3 10343212 (Pubitemid 29269667)
28. S Nasseri-Moghaddam H Razjouyan M Nouraei M Alimohammadi M Mamarabadi H Vahedi, et al. 2007 Inter- and intra-observer variability of the Los Angeles classification: a reassessment Arch Iranian Med 10 48 53